REPLIGEN CORP — Director's Dealing 2022

Jul 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-07-21

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-21	Common Stock	M	5000	$33.87	Acquired	204315	Direct
2022-07-21	Common Stock	M	15154	$32.40	Acquired	219469	Direct
2022-07-21	Common Stock	S	24802	$200.00	Disposed	194667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-21	Stock Option (Right to Buy)	$33.87	M	5000	Acquired	2028-02-29	Common Stock (5000)	Direct
2022-07-21	Stock Option (Right to Buy)	$32.40	M	15154	Acquired	2027-02-23	Common Stock (15154)	Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.

F2: This option is fully vested and exercisable.